Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: A still unresolved issue

Transplantation

Volumn 87, Issue 2, 2009, Pages 305-306

  Potena, Luciano ^a   Grigioni, Francesco ^a   Magnani, Gaia ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS INFECTION; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY GRAFT; LETTER; LIVER GRAFT; PRIORITY JOURNAL; TREATMENT OUTCOME; DRUG ADMINISTRATION; LIVER TRANSPLANTATION; METHODOLOGY; NOTE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICS;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DATA INTERPRETATION, STATISTICAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; LIVER TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 59649092635     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181938bdb     Document Type: Letter

References (5)

1. Yan L, Li B, Zeng Y, et al. Living donor liver transplantation for Budd-Chiari syndrome using cryopreserved vena cava graft in retrohepatic vena cava reconstruction. Liver Transpl 2006; 12: 1017.
2. Tanaka K, Uemoto S, Tokunaga Y, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993; 217: 82.
3. Jones VS, Shun A. Is the inferior vena cava dispensable? Pediatr Surg Int 2007; 23: 885.
4. Yamada T, Tanaka K, Ogura Y, et al. Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome. Am J Transplant 2006; 6: 2463.
5. Hardwigsen J, Baque P, Crespy B, et al. Resection of the inferior vena cava for neoplasms with or without prosthetic replacement: A 14-patient series. Ann Surg 2001; 233: 242.